Senior lecturer
M.D. 1986
|
Department : |
Neurology-Barzilai Hospital
|
|
Room : |
|
| Phone : |
|
| Email : |
ronm@bmc.gov.il |
| Office Hours : |
|
multiple sclerosis, t cells |
|
|
- Immuno-modulation in multiple sclerosis
- Cognitive impairment in multiple sclerosis
- Clinical trials in multiple sclerosis
Major expertise and techniques in the lab
- Generation and manipulation of antigen-specific T cell lines
Publications and funding summary / representative publications and grants
Milo R: The efficacy and safety of daclizumab and its potential role in the treatment of multiple sclerosis. Ther Adv Neurol Disord 2014;7:7-21.
Milo R, Miller A: Revised diagnostic criteria for multiple sclerosis. Autoimmun Rev 2014;13:518-24.
Milo R: Effectiveness of MS treatment with current immunomodulatory drugs. Expert Opin Pharmacother 2015;16:659-73.
Kaushansky N, Eisenstein M, Boura-Halfon S, Hanse BE, Nielsen CH, Milo R, Zeilig G, Lassmann H, Altmann DM, Ben-Nun A: Role of a novel HLA-DQA1*01:02;DRB1*15:01 mixed-isotype heterodimer in the pathogenesis of 'humanized' multiple sclerosis-like disease. J Biol Chem 2015;290:15260-78.
Milo R. Therapeutic strategies targeting B-cells in multiple sclerosis. Autoimmun Rev 2016;15(7):714-8.
Milo R, Panitch H: Additive effects of Copolymer-1 and Interferon beta-1b on the immune response to myelin basic protein. J Neuroimmunol 1995;61:185-193.
Jiang H, Milo R. Yong VW, Swoveland P, Johnson KP, Panitch H, Dhib-Jalbut S: Interferon beta-1b reduces interferon gamma-induced antigen-presenting capacity of human glial and B cells. J Neuroimmunol 1995;61:17-25.
Milo R, Kahana E: Multiple sclerosis: Geoepidemiology, genetics and the environment. Autoimmun Rev 2010;9:A387-94.
Milo R, Panitch H: Combination therapy in multiple sclerosis. J Neuroimmunol 2011;231:23–31.
Milo R, Panitch H: Additive effects of Copolymer-1 and Interferon beta-1b on the immune response to myelin basic protein. J Neuroimmunol 1995;61:185-193.
Jiang H, Milo R. Yong VW, Swoveland P, Johnson KP, Panitch H, Dhib-Jalbut S: Interferon beta-1b reduces interferon gamma-induced antigen-presenting capacity of human glial and B cells. J Neuroimmunol 1995;61:17-25.
Milo R, Kahana E: Multiple sclerosis: Geoepidemiology, genetics and the environment. Autoimmun Rev 2010;9:A387-94.
Milo R, Panitch H: Combination therapy in multiple sclerosis. J Neuroimmunol 2011;231:23–31.
- A. Ben-Nun, Department of Immunology, The Weizmann Institute of Science: “ The
- Prevalence of T-cells recognizing major myelin epitopes in the context of different DR15 alleles”.